Skip to content

The role of hydrogen sulfide signaling pathway in acupuncture treatment of functional dyspepsia

The role of hydrogen sulfide signaling pathway in acupuncture treatment of functional dyspepsia

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800020203
Enrollment
Unknown
Registered
2018-12-07
Start date
2018-11-29
Completion date
Unknown
Last updated
2019-01-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

functional dyspepsia

Interventions

FD acupuncture test group:acupuncture

Sponsors

Hubei College of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: FD pilot group inclusion criteria: 1. Aged 18-65 years old male and female; 2. It conforms to the diagnostic criteria of Rome IV functional dyspepsia: 3. Those who know about the study, volunteer to participate and sign the informed consent. Inclusion criteria for normal control group: 1. Aged 18-65 years old male and female; 2. Physical examination excludes functional gastrointestinal diseases and other organic diseases. 3. Those who know about the study, volunteer to participate and sign the informed consent.

Exclusion criteria

Exclusion criteria: 1. Taking routine use of gastrointestinal drugs within 15 days prior to the trial; 2. Patients with organic diseases that may affect gastrointestinal symptoms, such as malignant tumors in any part of the gastrointestinal tract, gastrointestinal infections, diabetes mellitus, eating disorders, etc., have undergone weight-loss surgery and gastrointestinal resection at any part of the patients; 3. Fainting in needling process; 4. Metal allergy; 5. Suffering from serious complications or diseases requiring urgent treatment; 6. Women who are pregnant or breast-feeding or planning to become pregnant, who are pregnant during the study period; 7. Patients receiving treatment for drug addiction or alcoholism or with a history of drug addiction or alcoholism; 8. Planned to participate in or have participated in other clinical studies; 9. For other reasons, it is considered unsuitable for researchers to participate in the study.

Design outcomes

Primary

MeasureTime frame
microRNA of plasma exosomes;Adult Functional Gastroenteropathy Diagnostic Questionnaire;

Countries

China

Contacts

Public ContactAilin Xiao

Hubei College of Traditional Chinese Medicine

71725947@qq.com+86 13797293552

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026